Trials / Unknown
UnknownNCT04128332
Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer
Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery in Pancreatic Adenocarcinoma: A Window of Opportunity Feasibility Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- CCTU- Cancer Theme · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
A window of opportunity feasibility study assessing pre-operative stereotactic ablative body radiotherapy followed by immediate surgery in pancreatic adenocarcinoma.
Detailed description
This is a single-centre, prospective, non-randomised feasibility study. This study will assess whether SABR can safely be given immediately prior to Whipple's resection by assessing the rate of post-operative complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Pre-operative stereotactic ablative body radiotherapy | Stereotactic ablative body radiotherapy is a highly focused radiation treatment that gives an intense dose of radiation concentrated on a tumour, while limiting the dose to the surrounding tissues. |
Timeline
- Start date
- 2020-10-26
- Primary completion
- 2021-12-01
- Completion
- 2022-12-01
- First posted
- 2019-10-16
- Last updated
- 2021-02-09
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04128332. Inclusion in this directory is not an endorsement.